Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults with von Hippel-Lindau disease who need treatment for associated renal cell carcinoma, central nervous system hemangioblastomas or pancreatic neuroendocrine tumors when immediate surgery is not required.
LAMPGEN ANALYSIS
Why it matters
The decision introduces HIF-2α inhibition for selected VHL-associated tumors.
What research teams should watch
Record the affected organs and surgical urgency and coordinate lesion imaging, anemia and oxygenation follow-up.
PRIMARY RECORDS